Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Redwood City, United States of AmericaPharmaceuticals & BiotechEnterprise
Developer of a cloud content governance platform intended for organizations to protect, connect, and unlock value from their content. The company's platform integrates with cloud, storage, device, and business applications to enable customers to optimize their collaboration environments through secure access, centralized control, and unified visibility, enabling clients to make informed decisions on infrastructure utilization and workflows and allowing end-users to access content intelligence.
Mountain View, United States of AmericaSoftware & SaaS
Provider of a diversified portfolio designed to support agricultural and energy needs. The company offers propane, biofuel, animal nutrition products, grains and other related products as well as is engaged in agronomy and agriculture technology, giving customers a one-stop-shop for their farm needs.
Cottage Grove, United States of AmericaRetail & E-commerce